Clinical Trial Material Transfer Agreement

This Clinical Trial Material Transfer Agreement (“Agreement”) is entered into as of (“Effective Date”) by and between:

1. Material

The Provider agrees to provide the following clinical trial material (“Material”) to the Recipient:

2. Use of Material

• The Material will be used solely for the following study/project:
• The Recipient shall not use the Material for commercial purposes.
• The Material shall not be transferred to or shared with any third party without written consent from the Provider.

3. Confidentiality

• Recipient agrees to keep confidential all information relating to the Material.
• The obligations of confidentiality shall survive termination of this Agreement.

4. Intellectual Property

• Provider retains all rights, title, and interest in the Material.
• Any inventions or discoveries arising from the use of the Material shall be handled as follows:

5. Publication

• Recipient shall have the right to publish results subject to Provider’s review to protect confidential information.

6. Term and Termination

• This Agreement shall commence on the Effective Date and continue until .
• Either party may terminate this Agreement at any time with written notice.

7. Liability

• The Material is provided “as is” without any warranty.
• The Provider shall not be liable for any damages arising from the use of the Material.

8. Miscellaneous

• This Agreement constitutes the complete understanding between parties.
• Amendments must be in writing and signed by both parties.
• Governing law:

Signatures